Table 5 Characteristics and genotype of the studies included in this meta-analysis
Author | Year | Age | MPO rs2234693/(rs9340799) | Control rs2234693/(rs9340799) | Method | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MPO | control | TT/(AA) | TC/(AG) | CC/(GG) | T/(A) | C/(G) | TT/(AA) | TC/(AG) | CC/(GG) | T/(A) | C/(G) | |||
Wang et al. [20] | 2017 | 62. 81 ± 5. 78 | 64. 21 ± 9. 22 | 78/99 | 53/36 | 11/7 | 209/234 | 75/50 | 59/93 | 62/46 | 30/12 | 180/232 | 122/70 | PCR-LDR |
Pontin et al. [16] | 2018 | > 40 | > 40 | 22/33 | 56/39 | 14/20 | 100/105 | 84/79 | 20/17 | 54/57 | 18/18 | 94/91 | 90/93 | PCR-RFLP |
Cisneros et al. [21] | 2019 | 66 ± 11.2 | 58.1 ± 8.4 | 91/(N/A) | 70/(N/A) | 19/(N/A) | 252/(N/A) | 108/(N/A) | 91/(N/A) | 78/(N/A) | 27/(N/A) | 260/(N/A) | 132/(N/A) | TaqMan |
Shu et al. | 2019 | 57.32 ± 6.62 | 54.62 ± 4.43 | 79/115 | 105/96 | 46/19 | 263/326 | 197/120 | 59/93 | 70/45 | 21/12 | 188/221 | 112/79 | Mass-Array |